company

DESITIN PHARMA AS

1383 ASKER

Return on Equity
5,74 %
Current Ratio
4,78
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue12 420 000
Net Income925 000
Total Assets20 159 000
Total Equity16 126 000
Income (NOK)2022
Revenue12 420 000
Expenditure11 161 000
Operating Profit1 260 000
Financial Income1 000
Financial Costs11 000
Financial Balance−10 000
Earnings Before Tax1 250 000
Tax324 000
Net Income925 000
Balance (NOK)2022
Total Fixed Assets881 000
Total Current Assets19 278 000
Total Assets20 159 000
Total Retained Equity15 776 000
Total Equity16 126 000
Total Long-Term Debt0
Total Current Debt4 032 000
Total Equity and Debt20 159 000
Cash flow (NOK)2022
Sales Income0
Other Income12 420 000
Revenue12 420 000
Cost of Goods Sold0
Salary Costs6 188 000
Depreciation308 000
Impairment0
Expenditure11 161 000
Operating Profit1 260 000
Financial Income1 000
Financial Costs11 000
Financial Balance−10 000
Dividends900 000
Net Income925 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures546 000
Total Tangible Assets546 000
Total Fiancial Fixed Assets335 000
Total Fixed Assets881 000
Stock0
Total Investments0
Cash, Bank18 605 000
Total Current Assets19 278 000
Total Assets20 159 000
Total Equity16 126 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors565 000
Unpaid Taxes262 000
Dividends900 000
Other Current Debt1 981 000
Total Current Debt4 032 000
Total Equity and Debt20 159 000
Financial indicators2022
Return on Equity5,74 %
Debt-to-Equity Ratio0
Operating Profit Margin10,14 %
Current Ratio4,78
Quick Ratio4,78
Equity Ratio0,8
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English